down arrow

Akums Drugs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
439.00
9.25 (2.15%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.77 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

433.70453.75

52 Week

407.401,174.85
Valuation
Technical
Day's Volume

CASH

1.77 lacs (-64.48%) Volume

Shareholding (Dec 2024)

FII

6.36%

Held by 33 FIIs

DII

7.00%

Held by 15 DIIs

Promoter

75.26%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 6,910 Cr (Mid Cap)

stock-summary
P/E

308.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

0.78%

stock-summary
Price to Book

2.39

Revenue and Profits (1 Year):
Net Sales:
1,010 Cr
(Quarterly Results - Dec 2024)
Net Profit:
65 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-48.76%
0%
-48.76%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Akums Drugs for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.30%
EBIT Growth (5y)
-101.18%
EBIT to Interest (avg)
2.41
Debt to EBITDA (avg)
4.31
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
1.24
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.36%
ROCE (avg)
-0.10%
ROE (avg)
11.75%
Valuation key factors
Factor
Value
P/E Ratio
308
Industry P/E
33
Price to Book Value
2.39
EV to EBIT
-2443.42
EV to EBITDA
52.85
EV to Capital Employed
2.53
EV to Sales
1.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.10%
ROE (Latest)
0.78%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Bearish
KST
Dow Theory
Bearish
Bearish
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 16 Schemes (5.54%)

FIIs

Held by 33 FIIs (6.36%)

Promoter with highest holding

Akums Master Trust (sanjeev Jain And Sandeep Jain) (40.79%)

Highest Public shareholder

Ruby Qc Investment Holdings Pte Ltd (4.62%)

Individual Investors Holdings

3.33%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2.76% vs 3.49% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -18.26% vs 20.27% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "337.41",
          "val2": "328.35",
          "chgp": "2.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.03",
          "val2": "43.07",
          "chgp": "-20.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.29",
          "val2": "4.18",
          "chgp": "-45.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "41.17",
          "val2": "50.37",
          "chgp": "-18.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.09%",
          "val2": "13.12%",
          "chgp": "-3.03%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "645.62",
          "val2": "762.61",
          "chgp": "-15.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "86.75",
          "val2": "-97.84",
          "chgp": "188.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.39",
          "val2": "8.68",
          "chgp": "19.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-18.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "92.24",
          "val2": "-136.93",
          "chgp": "167.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.44%",
          "val2": "-12.83%",
          "chgp": "26.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "983.03",
          "val2": "1,145.76",
          "chgp": "-14.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "120.78",
          "val2": "-66.13",
          "chgp": "282.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.68",
          "val2": "13.52",
          "chgp": "-6.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-18.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "133.41",
          "val2": "-107.59",
          "chgp": "224.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.29%",
          "val2": "-5.77%",
          "chgp": "18.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 12.22% vs 10.74% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -231.91% vs 132.85% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,444.12",
          "val2": "1,286.83",
          "chgp": "12.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-126.66",
          "val2": "241.88",
          "chgp": "-152.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.31",
          "val2": "13.18",
          "chgp": "38.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-19.39",
          "val2": "-144.53",
          "chgp": "86.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-165.45",
          "val2": "125.43",
          "chgp": "-231.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-8.77%",
          "val2": "18.80%",
          "chgp": "-27.57%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
337.41
328.35
2.76%
Operating Profit (PBDIT) excl Other Income
34.03
43.07
-20.99%
Interest
2.29
4.18
-45.22%
Exceptional Items
0.00
0.00
Standalone Net Profit
41.17
50.37
-18.26%
Operating Profit Margin (Excl OI)
10.09%
13.12%
-3.03%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.76% vs 3.49% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -18.26% vs 20.27% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
645.62
762.61
-15.34%
Operating Profit (PBDIT) excl Other Income
86.75
-97.84
188.67%
Interest
10.39
8.68
19.70%
Exceptional Items
0.00
-18.10
100.00%
Standalone Net Profit
92.24
-136.93
167.36%
Operating Profit Margin (Excl OI)
13.44%
-12.83%
26.27%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
983.03
1,145.76
-14.20%
Operating Profit (PBDIT) excl Other Income
120.78
-66.13
282.64%
Interest
12.68
13.52
-6.21%
Exceptional Items
0.00
-18.10
100.00%
Standalone Net Profit
133.41
-107.59
224.00%
Operating Profit Margin (Excl OI)
12.29%
-5.77%
18.06%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,444.12
1,286.83
12.22%
Operating Profit (PBDIT) excl Other Income
-126.66
241.88
-152.36%
Interest
18.31
13.18
38.92%
Exceptional Items
-19.39
-144.53
86.58%
Standalone Net Profit
-165.45
125.43
-231.91%
Operating Profit Margin (Excl OI)
-8.77%
18.80%
-27.57%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 12.22% vs 10.74% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -231.91% vs 132.85% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Akums Drugs & Pharmaceuticals Ltd stock-summary
stock-summary
Akums Drugs & Pharmaceuticals Ltd
Mid Cap
Pharmaceuticals & Drugs
Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."